Boundless Bio, Inc. · NASDAQ:BOLD
Citadel Advisors LLC's stake in Boundless Bio, Inc. fell to 0.60% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Citadel Advisors LLC's stake in Boundless Bio, Inc. fell to 0.60%, 145,118 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 0.60%
- Shares
- 145,118
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Citadel Advisors LLC | 0% | 0 |
| Citadel Advisors Holdings LP | 0% | 0 |
| Citadel GP LLC | 0% | 0 |
| Citadel Securities LLC | 0.30% | 65,617 |
| Citadel Securities Group LP | 0.60% | 145,118 |
| Citadel Securities GP LLC | 0.60% | 145,118 |
| Kenneth Griffin | 0.60% | 145,118 |
Source
Related
- Boundless Bio, Inc.
- Citadel Advisors LLC
- Boundless Bio, Inc. shareholders
- Schedule 13G · Citadel Advisors LLC · Dec 4, 2025
- Form 4 · Tang Kevin · Oct 20, 2026
- Form 4 · Tang Capital Management LLC · Aug 28, 2026
- Schedule 13G · Zachary Hornby · Aug 27, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Aug 14, 2026
- Form 4 · Tang Kevin · Jul 21, 2026